Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Methyl-β-cyclodextrin: Protocol and QC Guide
2026-09-08
Methyl-β-cyclodextrin (SKU C6939) is a soluble biochemical reagent for controlled membrane cholesterol extraction and related studies of membrane organization. It is intended for laboratory research only, not for diagnostic, clinical, or therapeutic workflows, and solutions should be prepared for prompt use rather than long-term storage.
-
Human SAN-Plexus Assembloids and Pacemaker Maturation
2026-09-08
The reference study develops human pluripotent stem cell-derived assembloids that combine sinoatrial node, cardiac plexus, and atrial-like tissues to model neural control of pacemaker maturation and conduction. By integrating functional assays with human SAN spatial transcriptomics, the authors identify a prosaposin–GPR37 signaling program that links cardiac ganglionated plexus cells to pacemaker development.
-
Oxaliplatin: Drug-Specific DNA Damage Assays
2026-09-07
Oxaliplatin is a platinum-based chemotherapeutic agent whose DNA adducts provide a powerful model for studying cancer chemotherapy. This article explains why cisplatin resistance biomarkers should not be transferred automatically to Oxaliplatin assays and presents practical design principles for cell and animal studies.
-
Bradykinin BA5201: Practical Assay Guide
2026-09-07
Bradykinin (BA5201) provides a defined research peptide for studying endothelium-dependent vasodilation, vascular permeability modulation, smooth muscle contraction, pain mechanisms, and inflammation-related responses. It is intended for controlled laboratory assays and should not be used for diagnosis, patient treatment, or long-term storage as a prepared solution.
-
T-5224 Triggers Ferroptosis in Myeloma via PI3K/AKT
2026-09-05
The reference study identifies ferroptosis, rather than apoptosis alone, as an important mechanism of T-5224-mediated killing of multiple myeloma cells. Its experiments connect AP-1 inhibition to suppression of PI3K/AKT signaling, loss of GPX4 and SLC7A11, oxidative stress, and enhanced interest in combining T-5224 with bortezomib.
-
S63845 MCL1 Inhibitor: Practical Research Workflows
2026-09-04
S63845 provides a selective way to test whether cancer-cell survival depends on MCL1 rather than relying on nonspecific cytotoxicity. This workflow connects mitochondrial apoptosis assays with combination studies involving death ligands, gemcitabine, and caspase-8/c-FLIPL signaling.
-
Ibotenic Acid: Dose, Time, and Neural Injury
2026-09-04
Ibotenic acid is a powerful NMDA receptor agonist for studying glutamatergic signaling, but its effects depend strongly on dose and observation time. This evidence-based guide shows how toxicity-aware experimental design can improve neuroscience assays and neurodegenerative disease models.
-
4-MUG for Lysosomal Enzyme Activity Assays
2026-09-03
4-Methylumbelliferyl-β-D-Glucopyranoside converts β-glucosidase and β-glucocerebrosidase activity into a sensitive, scalable fluorescence readout. This guide shows how to use 4-MUG in lysosomal disease models, enzyme kinetics, inhibitor screening, and functional studies of emerging GBA1 mRNA therapies.
-
A-769662: Practical AMPK Activation Workflows
2026-09-03
A-769662 provides reversible, direct AMPK stimulation for dissecting energy metabolism, lipid synthesis, and glucose regulation in cellular and animal models. Its additional 26S proteasome activity makes mechanism-specific controls essential, particularly when studying autophagy or cell-cycle phenotypes.
-
Ibotenic acid B6246 for Reliable Neurotoxicity Assays
2026-09-02
Learn how Ibotenic acid, SKU B6246, can be incorporated into controlled neuronal perturbation and cell viability workflows without confusing receptor-mediated metabolic changes with irreversible cytotoxicity. This evidence-based guide connects formulation, assay design, toxicity interpretation, and supplier-quality checks.
-
Ibotenic Acid: NMDA Agonist Research Guide
2026-09-02
Ibotenic acid is an NMDA receptor agonist and metabotropic glutamate receptor agonist used as a neuroscience research tool for controlled studies of excitatory signaling and neurodegenerative disease models. Product data identify B6246 as a 98% pure research compound, while a cited mouse study provides a circuit-level benchmark rather than direct validation of ibotenic acid.
-
Benzyl-activated Streptavidin Magnetic Beads for I/R Assays
2026-09-01
Build reproducible capture workflows around biotinylated annexin-V, proteins, nucleic acids, and interaction partners using magnetic separation instead of centrifugation-heavy processing. This guide connects early phosphatidylserine detection in ischemia–reperfusion research with practical bead optimization, controls, and troubleshooting.
-
AMPK, ULK1, and Autophagy Under Energy Stress
2026-09-01
The reference study challenges the prevailing view that AMPK uniformly promotes autophagy during glucose deprivation. Its experiments show that AMPK suppresses ULK1-driven autophagy during acute energy crisis while preserving the autophagy machinery for recovery, redefining how energy stress responses should be interpreted.
-
Toremifene in Prostate Cancer Research
2026-08-31
Toremifene is a second-generation selective estrogen-receptor modulator used to study estrogen receptor signaling and hormone-responsive cancer biology. Product documentation reports an approximately 1 ± 0.3 μM in vitro cell-growth inhibition benchmark in Ac-1 cells, while prostate cancer metastasis evidence separately identifies the TSPAN18–STIM1–Ca2+ axis as a mechanistic research target.
-
P2Y2R-Driven Microglial Aβ42 Clearance
2026-08-31
Kim et al. showed that fibrillar and oligomeric Aβ1–42 stimulate ATP release from primary microglia, linking extracellular nucleotide signaling to microglial migration, peptide uptake, and degradation through P2Y2 receptors. The study provides a mechanistic framework for interpreting Aβ clearance assays and for separating receptor-dependent phagocytosis from nonspecific cellular responses.